1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 04648004 2024-04-01 2025-03-31 04648004 2025-03-31 04648004 2024-03-31 04648004 2023-04-01 2024-03-31 04648004 2024-03-31 04648004 2023-03-31 04648004 bus:Director1 2024-04-01 2025-03-31 04648004 core:PlantMachinery 2025-03-31 04648004 core:WithinOneYear 2025-03-31 04648004 core:WithinOneYear 2024-03-31 04648004 core:ShareCapital 2025-03-31 04648004 core:ShareCapital 2024-03-31 04648004 core:RetainedEarningsAccumulatedLosses 2025-03-31 04648004 core:RetainedEarningsAccumulatedLosses 2024-03-31 04648004 bus:SmallEntities 2024-04-01 2025-03-31 04648004 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04648004 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04648004 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04648004 bus:FullAccounts 2024-04-01 2025-03-31 04648004 core:PlantMachinery 2024-04-01 2025-03-31 04648004 core:OfficeEquipment 2025-03-31 04648004 core:OfficeEquipment 2024-04-01 2025-03-31 04648004 core:KeyManagementPersonnel 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 04648004

Kanagasooriam Medical Limited

Filleted Unaudited Financial Statements

31 March 2025

Kanagasooriam Medical Limited

Financial Statements

Year ended 31 March 2025

Contents | Page

Statement of financial position | 1

Notes to the financial statements | 2

Kanagasooriam Medical Limited

Statement of Financial Position

31 March 2025

| 2025 | 2024
Note | £ | £ | £

Current assets

Debtors | 6 | 16 |  | 272
Cash at bank and in hand | 49,864 |  | 49,747
| -------- |  | --------
| 49,880 |  | 50,019

Creditors: amounts falling due within one year | 7 | 58,415 |  | 57,503
| -------- |  | --------
Net current liabilities |  | 8,535 | 7,484
|  | ------- | -------
Total assets less current liabilities |  | ( 8,535) | ( 7,484)
|  | ------- | -------
Net liabilities |  | ( 8,535) | ( 7,484)
|  | ------- | -------

Capital and reserves

Called up share capital |  | 200 | 200
Profit and loss account |  | ( 8,735) | ( 7,684)
|  | ------- | -------
Shareholders deficit |  | ( 8,535) | ( 7,484)
|  | ------- | -------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 28 May 2025 , and are signed on behalf of the board by:

Dr A J Kanagasooriam |
Director |

Company registration number: 04648004

Kanagasooriam Medical Limited

Notes to the Financial Statements

Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Camburgh House, 27 New Dover Road, Canterbury, CT1 3DN, Kent.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
After making appropriate enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future for at least one year from the date of the financial information. For these reasons they continue to adopt the going concern basis in preparing the company's financial information.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Plant and machinery | - | 3 Years Straight Line
| Equipment | - | 3 Years Straight Line

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Tangible assets

| Plant and machinery | Equipment | Total
| £ | £ | £
Cost |  |  |
At 1 April 2024 and 31 March 2025 | 673 | 250 | 923
| ---- | ---- | ----
Depreciation |  |  |
At 1 April 2024 and 31 March 2025 | 673 | 250 | 923
| ---- | ---- | ----
Carrying amount |  |  |
At 31 March 2025 | – | – | –
| ---- | ---- | ----
At 31 March 2024 | – | – | –
| ---- | ---- | ----

6. Debtors

| 2025 | 2024
| £ | £
Other debtors | 16 | 272
| ---- | ----

7. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Other creditors | 58,415 | 57,503
| -------- | --------

8. Related party transactions
At the year end the company owed the director £56,315 (2024: £56,003).